Work

Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with In Vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785)

Year: 1999

Type: article

Source: Biochemical Pharmacology

DOI: 10.1016/s0006-2952(98)00356-6

Authors: Carolyn M. Discafani, Marion L. Carroll, M.Brawner Floyd, Irwin J. Hollander, Zaheed Husain, Bernard D. Johnson, Douglas Kitchen, Michael K. May, Madhu S. Malo, Albert A. Minnick, Ramaswamy Nilakantan, Ru Shen, Yu-Fen Wang, Allan Wissner, Lee M. Greenberger

Institution: Wyeth

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1972132555

FWCI: 3.473

Cites: 31

Cited by: 111

Related to: 10